Radiotherapy
1 competing product in clinical development for Radiotherapy.
Pipeline by Phase
Phase 11
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| NBTXR3 + Nivolumab + Pembrolizumab | Nanobiotix | Phase 1 | Active | 28 |
1 competing product in clinical development for Radiotherapy.
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| NBTXR3 + Nivolumab + Pembrolizumab | Nanobiotix | Phase 1 | Active | 28 |